Article
Published 4 Apr 2025
Six Key Insights Into China Biotech's NewCo Model
Han Kun Law Offices
Your search returned 223 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 4 Apr 2025
揭秘中国创新药企NewCo模式实战中的"六脉神剑"
Han Kun Law Offices
Article
Published 2 Apr 2025
Safeguards Of Dapagliflozin's Half Billion USD Sales In China: AstraZeneca
Rouse
Article
Published 27 Mar 2025
CN 2025 Drafts On Clinical Trial Data Exclusivity
Toby Mak
Article
Published 28 Feb 2025
Application Of Bioisosterism In The Judgment Of Inventiveness
AFD China
Article
Published 29 Jan 2025
China Life Sciences: 2024 Year In Review
Arnold & Porter
Article
Published 23 Jan 2025
Chinese Regulators Publish Final Anti-Corruption Guidelines For The Healthcare Industry
Arnold & Porter
Article
Published 10 Jan 2025
医药企业申请商标的注意事项
CCPIT Patent & Trademark Law Office
Article
Published 9 Jan 2025
China Announces Major Policy Incentives For Life Sciences Companies
Ropes & Gray LLP
Article
Published 2 Jan 2025
2024 – Topics That May Concern You
CMS, China
Article
Published 30 Dec 2024
Circular On The Work Relating To The Implementation Of GB 9706.1-2020 And Supporting Concurrent Standards And Special Standards
CMS, China
Article
Published 30 Dec 2024
Further Strengthening The Supervision Of Entrusted Manufacturing Of Medical Devices: Key Takeaways From NMPA's New Notice
CMS, China
Article
Published 26 Dec 2024
Supreme People's Court Issued Interpretation On Punitive Damages For Food And Drug Disputes
CMS, China
Article
Published 26 Dec 2024
A New Adventure For Wholly Foreign Invested Hospital
CMS, China
Article
Published 10 Dec 2024
China's New Draft Administrative Measures For Management Of Medical Representatives
Arnold & Porter
Article
Published 5 Dec 2024
The New Draft Administrative Measures For Management Of Medical Representatives
Arnold & Porter
Article
Published 2 Dec 2024
글로벌 바이오의약 산업 특허출원 순위 TOP100 발표
Kangxin
Article
Published 28 Nov 2024
中国在医疗和生物技术领域的外资新政策：推动创新发展与加强专利保护
Lusheng Law Firm
Article
Published 28 Nov 2024
China's New Policies On Foreign Investment In Healthcare And Biotechnology
Lusheng Law Firm
Article
Published 27 Nov 2024
Relaxation Of Long-Standing Restrictions On Foreign Investment In The Healthcare Sector In China
McDermott Will & Emery